v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
CURRENT ASSETS    
Cash and cash equivalents $ 1,763 $ 72,970
Total current assets 1,763 72,970
TOTAL ASSETS 1,763 72,970
CURRENT LIABILITIES    
Accounts payable and accrued expenses 3,549,339 3,022,865
Other liabilities 207,938 207,938
Notes payable, net 2,805,253 2,968,271
Convertible debt 125,000
Total current liabilities 6,687,530 6,199,074
Convertible debt 125,000
Notes payable - other 12,625 13,333
TOTAL LIABILITIES 6,700,155 6,337,407
STOCKHOLDERS’ DEFICIT    
Common stock, $0.001 par value; 19,000,000,000 shares authorized, 3,032,746,878 and 565,709,873 shares issued and outstanding, respectively as of December 31, 2024, and 2023 3,032,746 565,710
Additional paid-in-capital 43,675,323 39,932,605
Accumulated deficit (53,406,461) (46,762,752)
TOTAL STOCKHOLDERS’ DEFICIT (6,698,392) (6,264,437)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 1,763 72,970
Series A Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIT    
Preferred A voting stock, $0.001; 10 shares authorized, 10 and -0- shares issued and outstanding, respectively as of December 31, 2024, and 2023